← Back to Search

ComBaT for Glaucoma

N/A

Waitlist Available

Led By Angela Elam

Research Sponsored by University of Michigan

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 14 months

Awards & highlights

No Placebo-Only Group

Summary

This trial looks into if more resources can help people get eye care to prevent blindness and glaucoma.

Who is the study for?

This trial is specifically for Black or African American individuals who have already taken part in the screening exam phase of the study. It aims to see if extra support and education can encourage them to regularly visit eye care professionals, potentially preventing blindness due to glaucoma.

What is being tested?

The ComBaT Glaucoma intervention is being tested to determine whether providing additional resources and education can improve a person's likelihood of seeking regular eye care services, which could help prevent vision loss from glaucoma.

What are the potential side effects?

Since this trial focuses on behavioral intervention through education rather than medication, there are no direct medical side effects. However, participants may experience changes in their healthcare routines.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 14 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 14 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 14 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Eye care utilization

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Eye concernExperimental Treatment1 Intervention

Those with a diagnosis of glaucoma or glaucoma suspect (or other concerning eye disease, such as diabetic retinopathy or macular degeneration) will be invited to participate in the ComBaT Glaucoma.

Do I qualify?Apply below to find out